Natural polyphenols are being tested both in preclinical and clinical settings for the treatment of different neurological disorders. The article describes the outcome of three polyphenols, resveratrol, epigallocatechin gallate,...Read More
Early growth outcomes in very low birth weight infants with bronchopulmonary dysplasia or fetal growth restriction.
Feb 18, 2020
To assess the growth outcomes at 18 months corrected age in very low birth weight (VLBW) infants compared to standardized norms, and in VLBW infants with and without bronchopulmonary dysplasia (BPD) or fetal growth restriction...Read More
Dec 27, 2019
The longer patients continue with buprenorphine treatment, the lower their risk of adverse outcomes. THURSDAY, Dec. 26, 2019 (HealthDay News) — Buprenorphine treatment may be needed for several years after an opioid...Read More